- MPX International (CSE:MPXI) subsidiary, Spartan Wellness, has entered into a service agreement with a Shoppers Drug Mart subsidiary
- Under the agreement, Spartan Wellness’ network of volunteers and professionals will perform clinical services for Shopper Drug Mart patients
- Services will include prescribing cannabinoid combination and strength, delivery methods, cannabis use education, and follow-up medical appointments
- Such clinical services have become more critical for medical cannabis users during the ongoing COVID-19 pandemic
- MPX International (MPXI) is up four per cent and is currently trading at C$0.13 per share
MPX International (CSE:MPXI) subsidiary, Spartan Wellness, has entered into a service agreement with a Shoppers Drug Mart subsidiary.
The agreement, dated July 1, 2020, is with Medical Cannabis by Shoppers Drug Mart. Under the agreement, Spartan Wellness’ network of volunteers and professionals will perform clinical services for Shopper Drug Mart’s patients.
These services will include prescribing cannabinoid combination and strength and delivery methods for patients using cannabis and cannabinoid-based medicines. Other available services will also include providing general cannabis use education and conducting follow-up medical appointments with patients.
Spartan Wellness originally began as an initiative to help veterans and first responders using medical cannabis as a harm-reduction medicine. Since then, the company has grown to provide services to a much wider patient base, including Canadians with anxiety, depression, PTSD, and chronic pain.
Spartan Wellness delivers much of its services through its virtual medical clinic online, and a network of volunteers and professionals. These services have become more critical for medical cannabis users during the ongoing COVID-19 pandemic.
MPX International’s Chairman, President, and CEO, W Scott Boyes, commented on the new partnership forged through Spartan Wellness.
“MPX International is pleased to be able to initiate its relationship with Shoppers Drug Mart, as we continue to build our medical cannabis business in Canada.
“The resources which we have developed through Spartan give us a unique capability to work with Shoppers to the benefit of both companies and, more notably, the patients served by Spartan and Medical Cannabis by Shoppers.
“The medical cannabis industry continues to quickly evolve in Canada, and we feel it is important to surround ourselves with industry leaders,” he said.
MPX International (MPXI) is up four per cent and is trading at C$0.13 per share at 10:47am EDT.
